Tailstorm Health INC recalls BEVACIZUMAB (AVASTIN)1.25mg/0.05mL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Sterility Assurance
- Products
-
- BEVACIZUMAB (AVASTIN)1.25mg/0.05mL
- Company
- Tailstorm Health INC
- Where it was sold
-
Nationwide Within U.S.
Nationwide
- Units affected
- 27,560 Syringes
- About this recall
- BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1